![]() |
ITC Limited (ITC.NS) Évaluation DCF
IN | Consumer Defensive | Tobacco | NSE
|

- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
ITC Limited (ITC.NS) Bundle
Que vous soyez un investisseur ou un analyste, cette calculatrice DCF ITC Limited (ITCNS) est votre ressource incontournable pour une évaluation précise. Préchargé avec des données réelles d'ITC Limited, vous pouvez ajuster les prévisions et observer instantanément les effets.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 489,790.8 | 489,528.1 | 600,813.6 | 702,452.2 | 703,154.9 | 715,650.8 | 728,368.8 | 741,312.8 | 754,486.8 | 767,895.0 |
Revenue Growth, % | 0 | -0.05363514 | 22.73 | 16.92 | 0.10004 | 1.78 | 1.78 | 1.78 | 1.78 | 1.78 |
EBITDA | 217,465.8 | 196,364.5 | 225,030.3 | 277,404.8 | 289,966.1 | 290,118.8 | 295,274.6 | 300,522.0 | 305,862.6 | 311,298.2 |
EBITDA, % | 44.4 | 40.11 | 37.45 | 39.49 | 41.24 | 40.54 | 40.54 | 40.54 | 40.54 | 40.54 |
Depreciation | 16,388.5 | 16,333.9 | 17,200.5 | 17,966.3 | 18,163.9 | 21,020.7 | 21,394.2 | 21,774.4 | 22,161.4 | 22,555.2 |
Depreciation, % | 3.35 | 3.34 | 2.86 | 2.56 | 2.58 | 2.94 | 2.94 | 2.94 | 2.94 | 2.94 |
EBIT | 201,077.3 | 180,030.6 | 207,829.8 | 259,438.5 | 271,802.2 | 269,098.1 | 273,880.3 | 278,747.5 | 283,701.2 | 288,742.9 |
EBIT, % | 41.05 | 36.78 | 34.59 | 36.93 | 38.65 | 37.6 | 37.6 | 37.6 | 37.6 | 37.6 |
Total Cash | 250,576.0 | 192,961.2 | 166,942.1 | 232,317.2 | 198,931.6 | 257,243.8 | 261,815.4 | 266,468.2 | 271,203.6 | 276,023.2 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | 25,624.8 | 25,017.0 | 24,619.0 | 29,561.7 | 40,258.2 | 34,885.9 | 35,505.9 | 36,136.9 | 36,779.0 | 37,432.7 |
Account Receivables, % | 5.23 | 5.11 | 4.1 | 4.21 | 5.73 | 4.87 | 4.87 | 4.87 | 4.87 | 4.87 |
Inventories | 89,655.3 | 105,072.2 | 109,735.9 | 119,141.3 | 143,028.8 | 136,453.3 | 138,878.3 | 141,346.3 | 143,858.2 | 146,414.7 |
Inventories, % | 18.3 | 21.46 | 18.26 | 16.96 | 20.34 | 19.07 | 19.07 | 19.07 | 19.07 | 19.07 |
Accounts Payable | 36,298.3 | 43,187.3 | 44,172.6 | 46,589.9 | 47,978.3 | 53,017.0 | 53,959.2 | 54,918.1 | 55,894.0 | 56,887.3 |
Accounts Payable, % | 7.41 | 8.82 | 7.35 | 6.63 | 6.82 | 7.41 | 7.41 | 7.41 | 7.41 | 7.41 |
Capital Expenditure | -24,411.5 | -18,366.4 | -21,416.4 | -27,429.9 | -35,625.3 | -30,446.5 | -30,987.5 | -31,538.2 | -32,098.7 | -32,669.1 |
Capital Expenditure, % | -4.98 | -3.75 | -3.56 | -3.9 | -5.07 | -4.25 | -4.25 | -4.25 | -4.25 | -4.25 |
Tax Rate, % | 24.62 | 24.62 | 24.62 | 24.62 | 24.62 | 24.62 | 24.62 | 24.62 | 24.62 | 24.62 |
EBITAT | 153,621.2 | 132,088.0 | 152,739.0 | 192,493.6 | 204,891.9 | 200,661.2 | 204,227.2 | 207,856.5 | 211,550.4 | 215,309.9 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | 66,616.4 | 122,135.4 | 145,242.7 | 171,099.2 | 154,234.9 | 208,221.9 | 192,531.2 | 195,952.7 | 199,435.0 | 202,979.2 |
WACC, % | 5.61 | 5.61 | 5.61 | 5.61 | 5.61 | 5.61 | 5.61 | 5.61 | 5.61 | 5.61 |
PV UFCF | ||||||||||
SUM PV UFCF | 850,841.6 | |||||||||
Long Term Growth Rate, % | 4.00 | |||||||||
Free cash flow (T + 1) | 211,098 | |||||||||
Terminal Value | 13,072,788 | |||||||||
Present Terminal Value | 9,948,199 | |||||||||
Enterprise Value | 10,799,041 | |||||||||
Net Debt | -3,225 | |||||||||
Equity Value | 10,802,265 | |||||||||
Diluted Shares Outstanding, MM | 12,489 | |||||||||
Equity Value Per Share | 864.93 |
What You Will Receive
- Authentic ITC Financial Data: Pre-filled with ITC Limited’s historical and projected data for accurate analysis.
- Fully Customizable Template: Easily adjust key inputs such as revenue growth, WACC, and EBITDA %.
- Real-Time Calculations: Instantly see updates to ITC's intrinsic value based on your modifications.
- Professional Valuation Tool: Tailored for investors, analysts, and consultants aiming for precise DCF outcomes.
- User-Friendly Interface: Intuitive layout and straightforward instructions suitable for all experience levels.
Key Features
- 🔍 Real-Life ITC Limited Financials: Pre-filled historical and projected data for ITC Limited (ITCNS).
- ✏️ Fully Customizable Inputs: Modify all essential parameters (yellow cells) including WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Integrated formulas to determine the intrinsic value of ITC Limited (ITCNS) using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize the valuation of ITC Limited (ITCNS) immediately after adjustments.
- Scenario Analysis: Evaluate and compare different outcomes based on various financial assumptions side-by-side.
How It Operates
- 1. Access the Template: Download and open the Excel file containing ITC Limited's (ITCNS) preloaded data.
- 2. Adjust Assumptions: Modify key inputs such as growth rates, WACC, and capital expenditures.
- 3. View Results in Real-Time: The DCF model automatically computes intrinsic value and NPV.
- 4. Explore Scenarios: Analyze various forecasts to evaluate different valuation results.
- 5. Present with Assurance: Share expert valuation insights to bolster your decision-making.
Why Opt for This Calculator?
- All-in-One Solution: Offers DCF, WACC, and financial ratio analyses in a single resource.
- Flexible Inputs: Modify the yellow-highlighted cells to explore different scenarios.
- In-Depth Analysis: Automatically computes the intrinsic value and Net Present Value for ITC Limited (ITCNS).
- Preloaded Information: Access to historical and projected data for precise baselines.
- High-Quality Output: Perfect for financial analysts, investors, and business advisors.
Who Can Benefit from This Product?
- Individual Investors: Make well-informed decisions about buying or selling ITC Limited (ITCNS) stock.
- Financial Analysts: Enhance valuation processes with ready-to-use financial models specific to ITC Limited (ITCNS).
- Consultants: Provide clients with professional valuation insights related to ITC Limited (ITCNS) swiftly and accurately.
- Business Owners: Gain insights into how major companies like ITC Limited (ITCNS) are valued to inform your own strategies.
- Finance Students: Master valuation techniques using real-world data and examples from ITC Limited (ITCNS).
Contents of the Template
- Historical Data: Contains ITC Limited's past financial records and foundational forecasts.
- DCF and Levered DCF Models: Comprehensive templates for determining the intrinsic value of ITC Limited (ITCNS).
- WACC Sheet: Pre-configured calculations for Weighted Average Cost of Capital.
- Editable Inputs: Adjust key drivers such as growth rates, EBITDA percentages, and CAPEX projections.
- Quarterly and Annual Statements: A thorough analysis of ITC Limited's financial performance.
- Interactive Dashboard: Dynamically visualize valuation results and future projections.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.